​

Establishment Labs Stock (NASDAQ:ESTA)

ForecastRevenueOwnershipFinancialsChartTranscripts
Establishment Labs by TradingView

Previous Close

$59.57

52W Range

$26.56 - $83.31

50D Avg

$69.74

200D Avg

$54.65

Market Cap

$1.76B

Avg Vol (3M)

$495.99K

Beta

0.96

Div Yield

-

ESTA Company Profile

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CR

Employees

1,034

IPO Date

Jul 19, 2018

Website

ESTA Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Asia Pacific$34.54M$48.41M$33.95M
EMEA$91.05M$78.21M$80.15M
Latin America$39.93M$35.00M$48.89M
North America$45.56M$4.41M-
Other Geographical Areas--$2.16M

Fiscal year ends in Dec 25 | Currency in USD

ESTA Financial Summary

Dec 25Dec 24Dec 23
Revenue$211.08M$166.03M$165.15M
Operating Income$-39.01M$-49.99M$-65.03M
Net Income$-51.06M$-84.60M$-78.50M
EBITDA$-32.77M$-56.22M$-58.31M
Basic EPS$-1.72$-3.00$-3.07
Diluted EPS$-1.72$-3.00$-3.07

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 24, 26 | 8:30 AM
Q3 25Nov 05, 25 | 8:30 AM
Q2 25Aug 08, 25 | 8:30 AM

Peer Comparison

TickerCompany
KMTSKestra Medical Technologies, Ltd.
SSIISS Innovations International, Inc.
CNMDCONMED Corporation
SYRESpyre Therapeutics, Inc.
AHCOAdaptHealth Corp.
ZYMEZymeworks Inc.
TDOCTeladoc Health, Inc.
UFPTUFP Technologies, Inc.
AZTAAzenta, Inc.
NVCRNovoCure Limited